Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引：0
|
作者：
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构：
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic-polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes
    Hesselink, DA
    van Gelder, T
    van Schaik, RHN
    Balk, AHMM
    van der Heiden, IP
    van Dam, T
    van der Werf, M
    Weimar, W
    Mathot, RAA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (06) : 545 - 556
  • [22] Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients
    Chen, B.
    Zhang, W.
    Fang, J.
    Jin, Z.
    Li, J.
    Yu, Z.
    Cai, W.
    XENOBIOTICA, 2009, 39 (12) : 931 - 938
  • [23] THE EFFECT OF CYP3A4 AND CYP3A5 POLYMORPHISMS ON THE TACROLIMUS PLASMA CONCENTRATION IN CHINESE POST RENAL TRANSPLANT RECIPIENTS
    Wen, Gaiyan
    Yuan, Hong
    Xi, Lanyan
    Huang, Zhijun
    Li, Ying
    Lu, Yao
    JOURNAL OF HYPERTENSION, 2016, 34 : E300 - E300
  • [24] Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Kato, T
    Habuchi, T
    JOURNAL OF UROLOGY, 2004, 171 (04): : 490 - 491
  • [25] Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis
    Shi, X. -J.
    Geng, F.
    Jiao, Z.
    Cui, X. -Y.
    Qiu, X. -Y.
    Zhong, M. -K.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (05) : 614 - 624
  • [26] Genetic Polymorphisms in CYP3A5 and MDR1 Genes and Their Correlations With Plasma Levels of Tacrolimus and Cyclosporine in Renal Transplant Recipients
    Mendes, J.
    Martinho, A.
    Simoes, O.
    Mota, A.
    Breitenfeld, L.
    Pais, L.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (03) : 840 - 842
  • [27] CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population
    Hu, YF
    He, J
    Chen, GL
    Wang, D
    Liu, ZQ
    Zhang, C
    Duan, LF
    Zhou, HH
    CLINICA CHIMICA ACTA, 2005, 353 (1-2) : 187 - 192
  • [28] Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients
    Moes, D. J. A. R.
    Swen, J. J.
    den Hartigh, J.
    van der Straaten, T.
    van der Heide, Homan J. J.
    Bemelman, F.
    de Fijter, J. W.
    Guchelaar, H. J.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 672 - 672
  • [29] CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant Recipients
    Crettol, Severine
    Venetz, Jean-Pierre
    Fontana, Massimiliano
    Aubert, John-David
    Pascual, Manuel
    Eap, Chin B.
    THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 689 - 699
  • [30] Influence of CYP3A4*22 and CYP3A5*3 genetic polymorphisms on tacrolimus pharmacokinetics in adult renal transplant patients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S709 - S709
12345